Osman M Saeed, MD | |
102 Medical Center Dr, Hazard, KY 41701-9421 | |
(606) 439-7998 | |
(606) 439-6701 |
Full Name | Osman M Saeed |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 102 Medical Center Dr, Hazard, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215046586 | NPI | - | NPPES |
3732449000 | Other | KY | PASSPORT |
CK2274 | Other | KY | RR MEDICARE GROUP |
64100142 | Medicaid | KY | |
2444451000 | Other | KY | PASSPORT GROUP |
6764 | Other | KY | MEDICARE GROUP |
P00716878 | Other | KY | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 39299 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Osman M Saeed, MD 10205 Springhurst Gardens Cir, Louisville, KY 40241-5194 Ph: (502) 412-8798 | Osman M Saeed, MD 102 Medical Center Dr, Hazard, KY 41701-9421 Ph: (606) 439-7998 |
News Archive
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.
The University of Minnesota's Midwest Center for Occupational Health and Safety is offering a Hearing Conservation course on April 21-23, 2010, designed for hearing conservation technicians and occupational health professionals seeking certification as an Occupational Hearing Conservationist.
A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University in Sweden in a study published in the scientific periodical The Journal of Experimental Medicine. Given that the tumour vasculature constitutes an important barrier to the spread of cancer cells, the team suggests that drugs should be developed to strengthen the blood vessels' protective function.
The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.
› Verified 8 days ago
Dr. Artie Ann Bates, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 Fax: 606-436-5797 | |
Prerana Suresh Kurtkoti, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 102 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6713 Fax: 606-439-6701 | |
Daniel R Lalonde Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Center Dr Ste 3l, Hazard, KY 41701 Phone: 606-487-7951 Fax: 606-487-7952 | |
Snehamala Veeravalli, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 102 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6713 Fax: 606-439-6701 | |
Joel Haffner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 Fax: 606-435-0817 | |
Burt H Weston, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 Fax: 606-435-0817 |